Pradip Mukerji

USPTO Granted Patents = 64 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 24

Forward Citations = 1,474(Granted Patents)

Inventors with similar research interests:

Location History:

Grahanna, OH (US) (1999)
Singapore, SG (2012)
Gahanna, OH (US) (1996 - 2014)
Columbus, OH (US) (2007 - 2014)

Company Filing History:

61 out of 4,177

Abbott Laboratories Corporation

University of Oklahoma

patents

4. 1 out of 6,954

Monsanto Technology LLC

patents

5. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2014

Loading Chart...

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8916361 - Elongase gene and uses thereof (2014-12-23),

2. 8916154 - Antibodies against delta-5 desaturase and uses thereof (2014-12-23),

3. 8796333 - Method of using β-hydroxy-β-methylbutyrate to treat a condition (2014-08-05),

4. 8785496 - Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting (2014-07-22),

5. 8785495 - Compositions including beta-hydroxy-beta-methylbutyrate (2014-07-22),

6. 8778994 - Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting (2014-07-15),

7. 8778993 - Method of using β-hydroxy-β-methylbutyrate for the treatment of disease conditions (2014-07-15),

8. 8778992 - Method of using beta-hydroxy-beta-methylbutyrate to treat allergies and asthma (2014-07-15),

9. 8778632 - Δ6-desaturase genes and uses thereof (2014-07-15),

10. 8722384 - Methods and compositions for synthesis of long chain polyunsaturated fatty acids (2014-05-13),

11. 8609725 - Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate (2013-12-17),

12. 8247653 - Delta-8 desaturase genes, enzymes encoded thereby and uses thereof (2012-08-21),

13. 8217077 - HMB uses thereof (2012-07-10),

14. 8188335 - Δ9-elongase for production of polyunsaturated fatty acid-enriched oils (2012-05-29),

15. 8143486 - Delta-5 desaturase and uses thereof (2012-03-27),

Title: Pradip Mukerji: Innovator in Biotechnology and Genetic Research

Introduction

Pradip Mukerji, based in Gahanna, Ohio, is a prolific inventor with an impressive portfolio of 64 patents. His contributions primarily lie in the fields of biotechnology and genetic research, showcasing a profound influence on advancements in these areas.

Latest Patents

Among Mukerji’s notable patents are "Antibodies against delta-5 desaturase and uses thereof" and "Elongase gene and uses thereof." The first patent discloses antibodies that specifically recognize delta-5 desaturase, including methods for their production and usage. These antibodies improve the detection of delta-5 desaturase in samples, enhancing research and diagnostic capabilities. The second patent relates to identifying a gene essential for elongating polyunsaturated fatty acids with unsaturation at the carbon 9 position. This invention enables the conversion of linoleic acid to eicosadienoic acid and further processing into dihomo-γ-linolenic acid and arachidonic acid, which are valuable in pharmaceuticals, nutritional products, animal feeds, and cosmetics.

Career Highlights

Pradip Mukerji has had a significant career, working with leading companies such as Abbott Laboratories and Calgene Corporation. His work at these organizations has led to substantial advancements in biotechnology and genetic engineering.

Collaborations

Throughout his career, Mukerji has collaborated with esteemed colleagues, including Yung-Sheng Huang and Jennifer M. Thurmond. These collaborations have undoubtedly contributed to the development of innovative solutions in their respective fields.

Conclusion

With a remarkable collection of patents and a career marked by significant contributions to biotechnology, Pradip Mukerji stands out as an influential inventor. His work continues to impact various industries, showcasing the importance of innovation in advancing science and technology.

This text is generated by artificial intelligence and may not be accurate.